SG11201907033SA - In vivo drug delivery devices and methods for drug delivery - Google Patents

In vivo drug delivery devices and methods for drug delivery

Info

Publication number
SG11201907033SA
SG11201907033SA SG11201907033SA SG11201907033SA SG11201907033SA SG 11201907033S A SG11201907033S A SG 11201907033SA SG 11201907033S A SG11201907033S A SG 11201907033SA SG 11201907033S A SG11201907033S A SG 11201907033SA SG 11201907033S A SG11201907033S A SG 11201907033SA
Authority
SG
Singapore
Prior art keywords
international
drug delivery
methods
drug
massachusetts
Prior art date
Application number
SG11201907033SA
Other languages
English (en)
Inventor
Heejin Lee
Emily Abbate
Sarah Hocking
Dennis Giesing
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Publication of SG11201907033SA publication Critical patent/SG11201907033SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/04—General characteristics of the apparatus implanted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1078—Urinary tract
    • A61M2210/1085—Bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201907033SA 2017-02-01 2018-02-01 In vivo drug delivery devices and methods for drug delivery SG11201907033SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762453333P 2017-02-01 2017-02-01
US201762480744P 2017-04-03 2017-04-03
PCT/US2018/016463 WO2018144738A1 (en) 2017-02-01 2018-02-01 In vivo drug delivery devices and methods for drug delivery

Publications (1)

Publication Number Publication Date
SG11201907033SA true SG11201907033SA (en) 2019-08-27

Family

ID=61231348

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907033SA SG11201907033SA (en) 2017-02-01 2018-02-01 In vivo drug delivery devices and methods for drug delivery

Country Status (22)

Country Link
US (3) US11020575B2 (lt)
EP (1) EP3432970B1 (lt)
JP (2) JP7366748B2 (lt)
KR (1) KR102564771B1 (lt)
CN (1) CN110418658A (lt)
AU (2) AU2018217094B2 (lt)
CY (1) CY1124192T1 (lt)
DK (1) DK3432970T3 (lt)
ES (1) ES2873084T3 (lt)
HR (1) HRP20210571T1 (lt)
HU (1) HUE054587T2 (lt)
IL (1) IL268385B (lt)
LT (1) LT3432970T (lt)
MX (2) MX2019009080A (lt)
PL (1) PL3432970T3 (lt)
PT (1) PT3432970T (lt)
RS (1) RS62459B1 (lt)
RU (1) RU2759868C2 (lt)
SG (1) SG11201907033SA (lt)
SI (1) SI3432970T1 (lt)
SM (1) SMT202100310T1 (lt)
WO (1) WO2018144738A1 (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377252B2 (en) * 2018-03-13 2025-08-05 Vertex Pharmaceuticals Incorporated Implantation devices, system, and methods
CN112839653A (zh) * 2018-08-01 2021-05-25 塔里斯生物医药公司 使用曲司氯铵治疗膀胱过度活动症的方法
CN109765118B (zh) * 2018-12-22 2021-09-17 临沂协润工贸有限公司 一种纺织品韧性测试仪
WO2022225379A1 (ko) * 2021-04-23 2022-10-27 김승범 과민성 방광 치료 장치
CN113274624B (zh) * 2021-07-06 2023-05-12 中南大学湘雅医院 一种可视化尿道扩张术后治疗仪
EP4710986A2 (en) 2021-12-21 2026-03-18 TARIS Biomedical LLC Urinary placement catheter for intravesical devices
KR20240145513A (ko) 2022-02-18 2024-10-07 타리스 바이오메디컬 엘엘씨 에르다피티닙 제형 및 방광내 투여를 위한 삼투성 시스템
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
CN120731077A (zh) 2023-02-17 2025-09-30 塔里斯生物医药公司 膀胱内施用厄达替尼以用于治疗膀胱癌
KR20250168664A (ko) 2023-04-10 2025-12-02 타리스 바이오메디컬 엘엘씨 바실루스 칼메트-구에린 요법에 무반응성인 고위험 근육 비침습성 방광암을 치료하는 방법에 사용하기 위한 젬시타빈
TW202532086A (zh) 2023-10-02 2025-08-16 美商塔里斯生物醫學有限責任公司 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法
WO2026058217A1 (en) 2024-09-13 2026-03-19 Taris Biomedical Llc Intravesical gemcitabine for use in treating bacillus calmette-guérin (bcg)-naive high-risk non-muscle invasive bladder cancer (hr-nmibc)

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210139A (en) 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
US4657536A (en) 1979-04-13 1987-04-14 Regents Of The University Of Minnesota Check valve catheter
US5340590A (en) 1987-06-25 1994-08-23 Alza Corporation Delivery system with bilayer osmotic engine
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5221278A (en) 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
DE69425453T2 (de) 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
US6436091B1 (en) * 1999-11-16 2002-08-20 Microsolutions, Inc. Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
US8740973B2 (en) * 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
DE602004012081T2 (de) 2003-03-31 2009-03-19 Intarcia Therapeutics, Inc., Emeryville Osmotische pumpe mit mitteln zum ableiten des innendrucks
MXPA06002967A (es) 2003-09-30 2006-06-14 Alza Corp Aparato de suministro de agente activo de conduccion osmotica que proporciona perfil de liberacion ascendente.
US7455688B2 (en) * 2004-11-12 2008-11-25 Con Interventional Systems, Inc. Ostial stent
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
US9586035B2 (en) * 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
EA201170297A1 (ru) * 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
US8721621B2 (en) 2009-09-10 2014-05-13 Taris Biomedical, Inc. Systems and methods for deploying devices to genitourinary sites
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8167836B2 (en) 2009-12-08 2012-05-01 Taris Biomedical, Inc. Tissue expander configured for drug delivery
PL3884988T3 (pl) 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
US20110218488A1 (en) 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
DK2600800T3 (da) * 2010-08-05 2020-11-16 Taris Biomedical Llc Indretning til lægemiddellevering i en ureterstent og kit dertil
JP5945544B2 (ja) * 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
US9457176B2 (en) * 2010-10-06 2016-10-04 Taris Biomedical Llc Implantable drug delivery device with bladder retention feature
US9114111B2 (en) 2011-01-10 2015-08-25 Allergan, Inc. Methods for sustained treatment of bladder pain and irritative voiding
AU2012211960B2 (en) 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
EP2844240A1 (en) * 2012-04-30 2015-03-11 Allergan, Inc. Methods for treatment of pelvic pain and / or comorbid conditions
CN104582782B (zh) * 2012-08-20 2018-11-27 奥雷制药有限公司 用于制备药物递送制剂的方法
BR112015005351A2 (pt) 2012-09-18 2017-07-04 Taris Biomedical Llc sistemas para distribuição de drogas e métodos para tratamento de disfunção de esvaziamento da bexiga e outros distúrbios do trato urinário inferior
EP2964310A1 (en) * 2013-03-05 2016-01-13 TARIS Biomedical LLC Drug delivery devices and methods for controlled drug release through device orifice
US9533101B2 (en) 2013-03-14 2017-01-03 Leonard Allen Massey, JR. Multi-cycle and auto-disable syringe and method of use thereof
JP6697376B2 (ja) * 2013-03-15 2020-05-20 タリス バイオメディカル エルエルシー 薬物送達のための薬物送達装置及び方法
PT2968880T (pt) * 2013-03-15 2025-07-07 Taris Biomedical Llc Dispositivos de aplicação de fármaco com componente permeável a fármaco
CN113413393B (zh) 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法
BR112016010103A8 (pt) * 2013-11-05 2018-01-30 Taris Biomedical Llc métodos, kits e dispositivos de suprimento de fármaco osmótico.
WO2016040904A1 (en) * 2014-09-12 2016-03-17 Taris Biomedical Llc Ph-modulating drug delivery devices and methods
CN104998344A (zh) * 2015-07-27 2015-10-28 肖雁冰 记忆合金硅胶宫内缓释系统

Also Published As

Publication number Publication date
DK3432970T3 (da) 2021-05-10
KR20190115035A (ko) 2019-10-10
JP2020505993A (ja) 2020-02-27
AU2018217094B2 (en) 2023-06-08
CA3052148A1 (en) 2018-08-09
CY1124192T1 (el) 2022-05-27
AU2023219908A1 (en) 2023-09-14
US20240424269A1 (en) 2024-12-26
RU2019126979A3 (lt) 2021-06-03
AU2023219908B2 (en) 2025-03-13
RU2021132576A (ru) 2021-12-13
SMT202100310T1 (it) 2021-07-12
JP7366748B2 (ja) 2023-10-23
PL3432970T3 (pl) 2021-09-20
ES2873084T3 (es) 2021-11-03
PT3432970T (pt) 2021-05-26
LT3432970T (lt) 2021-05-10
HRP20210571T1 (hr) 2021-09-03
IL268385A (en) 2019-09-26
RU2019126979A (ru) 2021-03-02
BR112019015812A2 (pt) 2020-03-31
EP3432970B1 (en) 2021-03-24
MX2024006288A (es) 2024-06-11
WO2018144738A1 (en) 2018-08-09
SI3432970T1 (sl) 2021-11-30
RU2759868C2 (ru) 2021-11-18
US12090292B2 (en) 2024-09-17
KR102564771B1 (ko) 2023-08-07
JP2023175989A (ja) 2023-12-12
US20190201329A1 (en) 2019-07-04
HUE054587T2 (hu) 2021-09-28
RS62459B1 (sr) 2021-11-30
AU2018217094A1 (en) 2019-08-22
US20210275789A1 (en) 2021-09-09
IL268385B (en) 2021-02-28
MX2019009080A (es) 2019-10-15
US11020575B2 (en) 2021-06-01
CN110418658A (zh) 2019-11-05
JP7789045B2 (ja) 2025-12-19
EP3432970A1 (en) 2019-01-30

Similar Documents

Publication Publication Date Title
SG11201907033SA (en) In vivo drug delivery devices and methods for drug delivery
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201901628XA (en) Methods and compositions for spinal cord cells
SG11201808231VA (en) Delivery system
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201906222WA (en) Jak1 selective inhibitors
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases
SG11201907604UA (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
SG11201811491YA (en) Quinazoline and indole compounds to treat medical disorders
SG11201408405WA (en) Engineered three-dimensional connective tissue constructs and methods of making the same
SG11201407241QA (en) Syringe
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201407793TA (en) Compounds and compositions for modulating egfr activity
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201804070XA (en) Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201804263PA (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
SG11201900443VA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201903312VA (en) Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201907505TA (en) Low-viscosity, high-concentration evolocumab formulations and methods of making the same
SG11201906742SA (en) Drug infusion device
SG11201803816RA (en) Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease